Creative Biolabs strives to transition iPSC technology into safe, effective and consistent therapies for various diseases and cancers effecting populations worldwide. Based on our extensive experience, now we can provide the teratoma formation assays to characterize the pluripotency of iPSCs for our customers all over the world. Check more about teratoma formation assay protocol: https://www.creative-biolabs.com/stem-cell-therapy/teratoma-formation-assays-for-ipsc.htm
#biotech